HEDGEHOG/GLI-E2F1 axis modulates iASPP expression and function and regulates melanoma cell growth

Area of Science:

• Oncology
• Molecular Biology
• Cell Signaling

Background:

• Aberrant Hedgehog (HH) signaling contributes to melanoma development.
• Cross-talk between HH signaling and p53 is observed in melanoma, where p53 function is often impaired.

Purpose of the Study:

• To investigate the role of HH signaling effectors (GLI1/GLI2) in regulating E2F1 in melanoma.
• To elucidate the functional significance of the HH/GLI-E2F1 axis in melanoma cell proliferation and survival.
• To identify how this axis modulates the inhibitor of apoptosis-stimulating protein of p53 (iASPP).

Main Methods:

• Analysis of GLI1/GLI2 binding to E2F1 promoter in melanoma cells.
• Correlation analysis of E2F1, PTCH1, GLI1, and GLI2 expression in human melanomas.
• Functional studies assessing melanoma cell proliferation and xenograft growth upon HH pathway activation.
• Investigation of iASPP regulation by the HH/GLI-E2F1 axis, including promoter binding and modulation of Cyclin B1 and CDK1.

Main Results:

• GLI1 and GLI2 directly regulate E2F1 transcription in melanoma cells.
• E2F1 is essential for HH pathway-induced melanoma cell proliferation and xenograft growth.
• The HH/GLI-E2F1 axis upregulates iASPP expression and activity through E2F1, Cyclin B1, and CDK1.
• Melanoma cell fate (proliferation vs. apoptosis) is dictated by the E2F1/iASPP complex in response to HH signaling.

Conclusions:

• A novel HH/GLI-E2F1-iASPP signaling axis promotes melanoma cell growth and survival.
• This axis restrains the proapoptotic function of p53 in melanoma.
• Targeting this pathway could offer new therapeutic strategies for melanoma.